Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Novo Nordisk's FY2024 results confirmed the structural nature of the GLP-1 demand wave: total revenues grew 26% to DKK 290.4 billion (approximately USD 41 billion), with Obesity care revenues up 56% to DKK 65.1 billion (approximately USD 8.2 billion)
Discard if cloudy or if particles are visible
Watch for adverse events and drug interactions
This product is strictly for research use only and is not intended for human or veterinary use
US$ 28.55
US$ 28.10
US$ 25.16
US$ 22.69
US$ 23.59
US$ 22.98
US$ 22.23
US$ 27.04
US$ 26.02
US$ 29.36
US$ 20.24
US$ 29.07
